OHSU Knight Cancer Institute

IRB #

IRB00006256

Title

[Wake Forest IRB - IREx] I-SPY 2 TRIAL: Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis 2

Principal Investigator

Alexandra Zimmer

Study Purpose

This study is being done to better understand how people respond to standard chemotherapy alone or combined with an investigational drug to treat breast cancer.

Medical Condition(s)

Invasive cancer of the breast

Eligibility Criteria

1. Men and women aged 18 years or older
2. Histologically confirmed breast cancer
3. No prior treatment for breast cancer
4. Willing and able to undergo biopsy of primary breast tumor

Age Range

18 - 100

Healthy Volunteers Needed

No

Duration of Participation

10 years

Minors Included

No

Contact

OHSU Knight Cancer Institute Information line 503-494-1080
trials@ohsu.edu

Sponsor

FNIH

Recruitment End

12/30/2030

Compensation Provided

No